Literature DB >> 16512825

Guidelines on the use and monitoring of heparin.

T Baglin1, T W Barrowcliffe, A Cohen, M Greaves.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16512825     DOI: 10.1111/j.1365-2141.2005.05953.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  44 in total

1.  Hip fracture: heparin is for thromboembolic prophylaxis.

Authors:  Michael L Jenkinson
Journal:  BMJ       Date:  2006-07-15

Review 2.  New anticoagulants: how to deal with treatment failure and bleeding complications.

Authors:  Rashid S Kazmi; Bashir A Lwaleed
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

3.  Cost-Effectiveness Analysis of the Unfractionated Heparin versus Low-Molecular-Weight Heparin in Hospitalized Patients with Stroke Due to Atrial Fibrillation in Shiraz, South of Iran.

Authors:  Nahid Hatam; Jamshid Bahmei; Khosro Keshavarz; Farnia Feiz; Reihaneh Sedghi; Afshin Borhani-Haghighi
Journal:  J Vasc Interv Neurol       Date:  2017-06

4.  Study of the Efficacy, Safety and Tolerability of Low-Molecular-Weight Heparin vs. Unfractionated Heparin as Bridging Therapy in Patients with Embolic Stroke due to Atrial Fibrillation.

Authors:  Farnia Feiz; Reyhane Sedghi; Alireza Salehi; Nahid Hatam; Jamshid Bahmei; Afshin Borhani-Haghighi
Journal:  J Vasc Interv Neurol       Date:  2016-06

5.  Concordance between Activated Partial Thromboplastin Time and Antifactor Xa Assay for Monitoring Unfractionated Heparin in Hospitalized Hyperbilirubinemic Patients.

Authors:  Leana Mahmoud; Andrew R Zullo; Donald McKaig; Christine M Berard-Collins
Journal:  R I Med J (2013)       Date:  2016-03-01

Review 6.  Are We Able to Dose Protamine Accurately Yet? A Review of the Protamine Conundrum.

Authors:  Patrick Hecht; Martin Besser; Florian Falter
Journal:  J Extra Corpor Technol       Date:  2020-03

Review 7.  Renal manifestations of the antiphospholipid syndrome.

Authors:  David D'Cruz
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

8.  Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience.

Authors:  John Quinn; Kate Von Klemperer; Ruth Brooks; Donald Peebles; Fiona Walker; Hannah Cohen
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

Review 9.  Update on the clinical use of the low-molecular-weight heparin, parnaparin.

Authors:  Giuseppe Camporese; Enrico Bernardi; Franco Noventa
Journal:  Vasc Health Risk Manag       Date:  2009-10-12

Review 10.  The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.

Authors:  Andrew D Blann; Chee W Khoo
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.